You are here
- Home
- Therapy Areas
- Neuroscience
A study to investigate the analgesic efficacy of AZD2423 compared with placebo after 28 days treatment in patients with posttraumatic neuralgia.
- Drug Name
- AZD2423
- Generic Name
- AZD2423
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- IIa
- Start Date
- Sep 18, 1971
- Study Name
- D2600C00012
- Study Id
- D2600C00012
- ClinicalTrials.gov ID
- NCT01200524
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
